The development of TRK inhibitors in cancer: A bedside-bench-bedside translational success

Dr. Robert C. Doebele, MD, PhD
Associate Professor of Medicine, University of Colorado School of Medicine
Thursday, May 23, 2019 - 12:30pm
PMH, 610 University Avenue, 8th Floor, Room 8-502
Invited Speaker Seminar
Host: 
Dr. Ming Tsao
OCI Special Seminar
Co-sponsor: 
Bayer Inc. and The Department of Medical Biophysics